Our investment portfolio companies span Europe, North America and Israel and cover the fields of pharmaceutical treatment and diagnosis of disease and conditions in dermatology, hepatology, infectious disease, oncology, pain and urology. 4 companies are listed on North American stock exchanges and the majority of the portfolio is in advanced development or approved and launched in major countries.